Literature DB >> 11461998

Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.

M A Khan1, C Aberham, S Kao, H Akari, R Gorelick, S Bour, K Strebel.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Vif protein plays a critical role in the production of infectious virions. Previous studies have demonstrated the presence of small amounts of Vif in virus particles. However, Vif packaging was assumed to be nonspecific, and its functional significance has been questioned. We now report that packaging of Vif is dependent on the packaging of viral genomic RNA in both permissive and restrictive HIV-1 target cells. Mutations in the nucleocapsid zinc finger domains that abrogate packaging of viral genomic RNA abolished packaging of Vif. Additionally, an RNA packaging-defective virus exhibited significantly reduced packaging of Vif. Finally, deletion of a putative RNA-interacting domain in Vif abolished packaging of Vif into virions. Virion-associated Vif was resistant to detergent extraction and copurified with components of the viral nucleoprotein complex and functional reverse transcription complexes. Thus, Vif is specifically packaged into virions as a component of the viral nucleoprotein complex. Our data suggest that the specific association of Vif with the viral nucleoprotein complex might be functionally significant and could be a critical requirement for infectivity of viruses produced from restrictive host cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461998      PMCID: PMC114961          DOI: 10.1128/JVI.75.16.7252-7265.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

Review 1.  HIV accessory proteins: leading roles for the supporting cast.

Authors:  D Trono
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

2.  Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.

Authors:  J Goncalves; B Shi; X Yang; D Gabuzda
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.

Authors:  E Kondo; F Mammano; E A Cohen; H G Göttlinger
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.

Authors:  U von Schwedler; J Song; C Aiken; D Trono
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr.

Authors:  E Kondo; H G Göttlinger
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

6.  Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes.

Authors:  J H Simon; T E Southerling; J C Peterson; B E Meyer; M H Malim
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.

Authors:  M Simm; M Shahabuddin; W Chao; J S Allan; D J Volsky
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  T Dorfman; J Luban; S P Goff; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.

Authors:  H Liu; X Wu; M Newman; G M Shaw; B H Hahn; J C Kappes
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants.

Authors:  T R Reddy; G Kraus; O Yamada; D J Looney; M Suhasini; F Wong-Staal
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  67 in total

1.  RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes.

Authors:  Shainn-Wei Wang; Anna Aldovini
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.

Authors:  Silke Wissing; Nicole L K Galloway; Warner C Greene
Journal:  Mol Aspects Med       Date:  2010-06-09

3.  Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses.

Authors:  Shainn-Wei Wang; Kristin Noonan; Anna Aldovini
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

4.  Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.

Authors:  Reynel Cancio; Silvio Spadari; Giovanni Maga
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

5.  Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors:  Judd F Hultquist; Reuben S Harris
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

6.  Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Authors:  Rajesh Thippeshappa; Patricia Polacino; Monica T Yu Kimata; Edward B Siwak; David Anderson; Weiming Wang; Laura Sherwood; Reetakshi Arora; Michael Wen; Paul Zhou; Shiu-Lok Hu; Jason T Kimata
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

Review 7.  Advances in the structural understanding of Vif proteins.

Authors:  Pierre Barraud; Jean-Christophe Paillart; Roland Marquet; Carine Tisné
Journal:  Curr HIV Res       Date:  2008-03       Impact factor: 1.581

8.  Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child.

Authors:  Louis Alexander; Mary Janette Aquino-DeJesus; Michael Chan; Warren A Andiman
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.

Authors:  Sandra Kao; Mohammad A Khan; Eri Miyagi; Ron Plishka; Alicia Buckler-White; Klaus Strebel
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif.

Authors:  Sandra Kao; Ritu Goila-Gaur; Eri Miyagi; Mohammad A Khan; Sandrine Opi; Hiroaki Takeuchi; Klaus Strebel
Journal:  Virology       Date:  2007-09-06       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.